Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Human Genome Sequencing Center Clinical Lab, |
RCV000709728 | SCV000839966 | likely pathogenic | Long QT syndrome 2 | 2017-06-05 | criteria provided, single submitter | clinical testing | This c.245T>C (p.Ile82Thr) variant in the KCNH2 gene has previously been reported in dizigotic twins with long QT syndrome (LQTS) and a history of epilepsy controlled under medication [PMID 23899126]. The mother and grandmother had LQTS and died suddendly in their 20s. One of the twins died suddendly at 18 y/o and the sister underwent implantation of a cardioverter-defibrillator. Functional studies for this variant revealed a severe reduction in current density and modifications of gating properties, indicating a loss of function mechanism. This variant is not present in the ExAC population database and has not been previously observed in our patient's cohort. Isoleucine at amino acid position 82 of the KCNH2 protein is moderately conserved in mammals. While not clinically validated, computer-based algorithms predict this p.Ile82Thr change to be deleterious. It is thus interpreted as a likely pathogenic variant. |